# DESCRIPTION

## FIELD OF THE DISCLOSURE

- define metastatic gene signatures

## BACKGROUND ART

- motivate need for metastasis prediction

## SUMMARY OF THE DISCLOSURE

- introduce method for metastasis risk determination
- describe metastatic gene signature sets
- outline method steps for risk determination
- explain metastatic potential score calculation

## DETAILED DESCRIPTION

- introduce risk model for predicting metastasis of prostate cancer

### Metastatic Gene Signature

- develop metastatic gene signature set from studies of genomic landscape of copy number alterations
- identify 368 genes associated with metastasis
- describe clumps of genes with copy number alterations
- define genomic region and clump
- provide examples of genes with deletions and amplifications
- describe smaller metastatic gene signature sets
- determine hierarchy of genes contributing to prediction
- provide examples of top genes and genomic regions
- describe determination of copy number alterations
- design nucleic acid probes for detection of CNAs
- describe hybridization and detection methods
- provide examples of techniques for analyzing chromosomal alterations

### Determination of Risk

- correlate copy number alterations with risk of metastasis
- describe calculation of metastatic potential score
- compare metastatic potential score to reference distribution
- correlate increase in metastatic potential score with increased risk of metastasis
- provide examples of reference scores and odds ratios
- describe significance of predictor for diagnosis and treatment of prostate cancer

### Diagnostic Kits

- describe diagnostic kits for performing methods

## EXAMPLES

- introduce examples of predictive metastasis model

### Example 1

- describe predictive biomarkers
- summarize sample processing and data analysis
- outline study design and metastasis prediction model
- describe analytical pipeline for developing metastatic potential clinical risk model
- summarize metastasis prediction model statistics

### Example 2

- describe analytical pipeline for developing metastatic potential clinical risk model
- outline copy number amplification and deletion events
- describe bootstrap clustering method
- summarize quantitative copy number differences
- describe weighted-Z scoring risk model

### Example 3

- describe metastatic potential score distributions
- summarize cross-validation and survival analysis
- describe biomarker functional significance
- outline molecular functions related to alteration of nuclear and extra-cellular matrix structure
- describe metabolic modification that enhance processes characteristic of metastasis
- summarize genes within amplified or deleted regions
- describe functional significance of SLC7A5 gene
- outline other solute carrier superfamily members

### Example 4

- describe ranking metastasis genes on the basis of predictability
- summarize performance of ranking method

### Example 5

- describe reporting prediction to patients

### Example 6

- validate metastasis signature

